Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 in Pediatric Systemic Lupus Erythematosus
NCT07096557Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Coenzyme Q10 mucoadhesive tablets in systemic lupus erythematosus (SLE) (2 arms), sponsored by Ain Shams University. Primary endpoint: Mitochondrial dysfunction at 3 months. Started Jan 2024; status: completed.
02
Drugs
Coenzyme Q10 mucoadhesive tablets
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT07096557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07096557.